Terms: = Gastric cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Clinical Outcome
350 results:
1. Da Vinci robot-assisted endoscopic full-thickness gastric resection with regional lymph node dissection using a 3D near-infrared video system: a single-center 5-year clinical outcome.
Lee AY; Kim MC; Cho S; Yoo IK; Kim YM; Lee TH; Seo JY; Kim SH; Cho JY
Surg Endosc; 2024 Apr; 38(4):2124-2133. PubMed ID: 38443502
[TBL] [Abstract] [Full Text] [Related]
2. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
3. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
4. Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Xiong JX; Li YT; Tan XY; Chen T; Liu BH; Fu L
Acta Pharmacol Sin; 2024 Feb; 45(2):405-421. PubMed ID: 37814123
[TBL] [Abstract] [Full Text] [Related]
5. Predictive factors and prognosis of upper gastrointestinal bleeding in gastric cancer: A large population-based study (UGIB-GC trial).
Kiattiweerasak A; Bongkotvirawan P; Aumpan N; Yamaoka Y; Miftahussurur M; Vilaichone RK
PLoS One; 2023; 18(9):e0291926. PubMed ID: 37729185
[TBL] [Abstract] [Full Text] [Related]
6. Comparing effectiveness and safety of paclitaxel plus raltitrexed
Zhao X; Chen Z; Zhang X; Zhu X; Zhang W; Qiu L; Wang C; Huang M; Zhang Z; Li W; Yang L; Guo W
Cancer Biol Med; 2023 Aug; 20(9):682-8. PubMed ID: 37653589
[TBL] [Abstract] [Full Text] [Related]
7. Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
Veldhuizen GP; Röcken C; Behrens HM; Cifci D; Muti HS; Yoshikawa T; Arai T; Oshima T; Tan P; Ebert MP; Pearson AT; Calderaro J; Grabsch HI; Kather JN
Gastric Cancer; 2023 Sep; 26(5):708-720. PubMed ID: 37269416
[TBL] [Abstract] [Full Text] [Related]
8. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
Gravis G; Marino P; Olive D; Penault-LLorca F; Delord JP; Simon C; Lamrani-Ghaouti A; Sabatier R; Ciccolini J; Boher JM
BMC Cancer; 2023 May; 23(1):393. PubMed ID: 37131154
[TBL] [Abstract] [Full Text] [Related]
9. ALCAM, Activated Leukocyte Cell Adhesion Molecule, in clinical gastric cancer and Patient's Response to Chemotherapies.
Yang YM; Ruge F; Ji KE; Jia S; Jia Y; Sanders AJ; Ji J; Jiang WG
Anticancer Res; 2023 Apr; 43(4):1463-1475. PubMed ID: 36974802
[TBL] [Abstract] [Full Text] [Related]
10. Quality performance indicator compliance for the treatment of gastric adenocarcinoma.
Wang Y; Kulasegaran S; Srinivasa S; Koea J; MacCormick A
ANZ J Surg; 2023 May; 93(5):1294-1299. PubMed ID: 36825561
[TBL] [Abstract] [Full Text] [Related]
11. outcomes of feeding jejunostomy after pancreaticoduodenectomy: A single-center experience.
Yamamoto N; Aoyama T; Murakawa M; Kamiya M; Shiozawa M; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S444-S448. PubMed ID: 36511001
[TBL] [Abstract] [Full Text] [Related]
12. Combined high NEDD9 expression and E-cadherin loss correlate with poor clinical outcome in gastric cancer.
Im S; Cho YK; Kang D; Shin GY; Jung ES; Song KY; Lee SH; Park JM
J Gastroenterol Hepatol; 2022 Dec; 37(12):2255-2263. PubMed ID: 36203318
[TBL] [Abstract] [Full Text] [Related]
13. [Real-world data analysis of 3012 patients undergoing laparoscopic radical gastrectomy in a single center over the past 12 years].
Wang LJ; Li Z; Wang S; Liu HD; Li QY; Li BW; Xu JH; Ge H; Wang WZ; Li FY; He ZY; Zhang DC; Xu H; Yang L; Xu ZK
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Aug; 25(8):716-725. PubMed ID: 35970806
[No Abstract] [Full Text] [Related]
14. gastric defect closure after endoscopic full-thickness resection: the closing while dissecting technique.
Sun H; Cao T; Zhang F; Tao K; Xu H
Surg Endosc; 2023 Jan; 37(1):234-240. PubMed ID: 35920910
[TBL] [Abstract] [Full Text] [Related]
15. Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol.
Huemer F; Hecht S; Scharinger B; Schlintl V; Rinnerthaler G; Schlick K; Heregger R; Melchardt T; Wimmer A; Mühlbacher I; Koch OO; Neureiter D; Klieser E; Seyedinia S; Beheshti M; Greil R; Weiss L
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3051-3064. PubMed ID: 35864270
[TBL] [Abstract] [Full Text] [Related]
16. Malignancy Diseases in Kidney Transplantation, clinical outcomes, Patient, and Allograft Survival: A Case-Control Study.
Pinto-Filho VA; Nascimento E; Cunha APL; Assis BPS; Lasmar MF; Vianna HR; Fabreti-Oliveira RA
Transplant Proc; 2022 Jun; 54(5):1253-1261. PubMed ID: 35750515
[TBL] [Abstract] [Full Text] [Related]
17. Identification of specific role of SNX family in gastric cancer prognosis evaluation.
Hu B; Yin G; Sun X
Sci Rep; 2022 Jun; 12(1):10231. PubMed ID: 35715463
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of the immune checkpoint HLA-G/ILT-4 in the survival of patients with gastric cancer.
Chen QY; Zhou WJ; Zhang JG; Zhang X; Han QY; Lin A; Yan WH
Int Immunopharmacol; 2022 Aug; 109():108798. PubMed ID: 35569305
[TBL] [Abstract] [Full Text] [Related]
19. Low clarithromycin resistance in virulent Helicobacter pylori from dyspeptic patients at a tertiary care centre in Odisha.
Hallur V; Panigrahi M; Sable M; Ghosh M; Mohanty S; Purkait S; Praharaj A
Indian J Med Microbiol; 2022; 40(2):211-216. PubMed ID: 35346525
[TBL] [Abstract] [Full Text] [Related]
20. clinical outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study.
Fujii H; Iwaki M; Hayashi H; Toyoda H; Oeda S; Hyogo H; Kawanaka M; Morishita A; Munekage K; Kawata K; Yamamura S; Sawada K; Maeshiro T; Tobita H; Yoshida Y; Naito M; Araki A; Arakaki S; Kawaguchi T; Noritake H; Ono M; Masaki T; Yasuda S; Tomita E; Yoneda M; Kawada N; Tokushige A; Kamada Y; Takahashi H; Ueda S; Aishima S; Sumida Y; Nakajima A; Okanoue T;
Clin Gastroenterol Hepatol; 2023 Feb; 21(2):370-379. PubMed ID: 35051649
[TBL] [Abstract] [Full Text] [Related]
[Next]
